Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb;16(2):1-5.

Therapeutic advances in cutaneous T-cell lymphoma

Oleg E Akilov  1 , Larisa Geskin
Affiliations
Review

Therapeutic advances in cutaneous T-cell lymphoma

Oleg E Akilov et al. Skin Therapy Lett. 2011 Feb.

Abstract

A variety of novel therapeutic modalities have recently become available for patients with cutaneous T cell lymphoma (CTCL). In particular, with recent FDA approvals of the three new agents vorinostat (Zolinza), romidepsin (Istodax), and pralatrexate (Folotyn) CTCL treatment has been transformed. Here, we offer a brief overview of these agents and discuss their place in the spectrum of current therapies for CTCL.

PubMed Disclaimer

References

    1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005 May 15;105(10):3768–85. - PubMed
    1. Reitamo S, Rissanen J, Remitz A, et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol. 1998 Sep;111(3):396–8. - PubMed
    1. Geskin L, McCann S, Vetter C, et al. Topical Tacrolimus is effective in the treatment of pruritus in patients with cutaneous T-cell lymphoma. Paper presented at: American Academy of Dermatology Annual Meeting; March 2003; San Francisco, CA.
    1. Orenstein A, Haik J, Tamir J, et al. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application. Dermatol Surg. 2000 Aug;26(8):765–9. - PubMed
    1. Rittenhouse-Diakun K, Van Leengoed H, Morgan J, et al. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA) Photochemistry and photobiology. 1995 May;61(5):523–8. - PubMed

MeSH terms

Substances